The Keloid Area and Severity Index (KASI): an objective tool for the evaluation of keloids.


Journal

The British journal of dermatology
ISSN: 1365-2133
Titre abrégé: Br J Dermatol
Pays: England
ID NLM: 0004041

Informations de publication

Date de publication:
11 2022
Historique:
revised: 03 06 2022
received: 21 12 2021
accepted: 11 06 2022
pubmed: 15 6 2022
medline: 5 11 2022
entrez: 14 6 2022
Statut: ppublish

Résumé

To aid in the standardization of evaluating patients with multiple keloids, a Keloid Area and Severity Index (KASI) was developed using patient feedback, previous literature, and clinical expertise. The system was validated using intrarater and interrater reliability assessments. Here, we present a verified, reliable method of assessing keloid area and severity in clinical and research settings.

Identifiants

pubmed: 35700059
doi: 10.1111/bjd.21705
doi:

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

799-800

Informations de copyright

© 2022 British Association of Dermatologists.

Références

Nicholas RS, Falvey H, Lemonas P et al. Patient-related keloid scar assessment and outcome measures. Plast Reconstr Surg 2012; 129:648.
Bae SH, Bae YC. Analysis of frequency of use of different scar assessment scales based on the scar condition and treatment method. Arch Plast Surg 2014; 41:111-15.
Bagabir R, Byers RJ, Chaudhry IH et al. Site-specific immunophenotyping of keloid disease demonstrates immune upregulation and the presence of lymphoid aggregates. Br J Dermatol 2012; 167:1053-66.
Tikuisis P, Meunier P, Jubenville C. Human body surface area: measurement and prediction using three dimensional body scans. Eur J Appl Physiol 2001; 85:264-71.
Guy WM, Pattisapu P, Ongkasuwan J, Brissett AE. Creation of a head and neck keloid quality of life questionnaire. Laryngoscope 2015; 125:2672-6.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19:210-16.
Ogawa R, Akita S, Akaishi S et al. Diagnosis and treatment of keloids and hypertrophic scars - Japan Scar Workshop consensus document 2018. Burns Trauma 2019; 7:39.
Tan A, Martinez Luna O, Glass DA 2nd. Pentoxifylline for the prevention of postsurgical keloid recurrence. Dermatol Surg 2020; 46:1353-6.

Auteurs

Eva Kerby (E)

Department of Dermatology, Weill Cornell Medicine, New York, NY, USA.

Shelby Lies (S)

Department of Plastic Surgery.

Byron Limmer (B)

Limmer Dermatology, San Antonio, TX, USA.

Rachel Limmer (R)

Limmer Dermatology, San Antonio, TX, USA.

Noelle Teske (N)

Department of Dermatology.

Stephanie Savory (S)

Department of Dermatology.

Joan S Reisch (JS)

Department of Population and Data Sciences.
Department of Family and Community Medicine, UT Southwestern Medical Center, Dallas, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH